Codes in this range
787 of the 787 codes carry a published October 2026 payment limit; the remaining codes are priced by contractors or carry a limit of zero in the file.
| Code | Descriptor | Unit | Limit | MUE | Col-2 pairs | Articles |
|---|---|---|---|---|---|---|
| J0014 | Cocaine hydrochloride nasal solution (goprelto), 1 mg | 1 MG | $1.825 | — | — | — |
| J0121 | Injection, omadacycline, 1 mg | 1 MG | $4.293 | 200 | — | — |
| J0122 | Injection, eravacycline, 1 mg | 1 MG | $1.333 | 300 | — | — |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug | 10 MG | $45.937 | 100 | — | — |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 10 MG | $0.044 | 400 | — | — |
| J0132 | Injection, acetylcysteine, 100 mg | 100 MG | $0.499 | 12 | — | — |
| J0133 | Injection, acyclovir, 5 mg | 5 MG | $0.048 | 1200 | — | — |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to | 10 MG | $0.051 | 400 | — | — |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 | 10 MG | $0.046 | 400 | — | — |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 10 MG | $0.048 | 400 | — | — |
| J0138 | Injection, acetaminophen 10 mg and ibuprofen 3 mg | 10 MG/3MG | $0.129 | 400 | — | — |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate | 1 MG | $0.378 | 180 | — | yes |
| J0162 | Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, | 0.1 MG | $0.321 | 20 | — | — |
| J0163 | Injection, epinephrine in sodium chloride (endo), 0.1 mg | 0.1 MG | $0.71 | — | — | — |
| J0164 | Injection, epinephrine in sodium chloride (baxter), 0.1 mg | 0.1 MG | $0.912 | — | — | — |
| J0165 | Injection, epinephrine, not otherwise specified, 0.1 mg | 0.1 MG | $0.206 | 20 | — | — |
| J0166 | Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg | 0.1 MG | $0.83 | 20 | — | — |
| J0167 | Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 | 0.1 MG | $1.422 | 20 | — | — |
| J0168 | Injection, epinephrine (international medication systems), not therapeutically | 0.1 MG | $2.697 | 20 | — | — |
| J0169 | Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, | 0.1 MG | $0.869 | 20 | — | — |
| J0174 | Lecanemab-irmb, for intravenous injection, 1 mg | 1 MG | $1.361 | — | — | — |
| J0175 | Injection, donanemab-azbt, 2 mg | 2 MG | $4.185 | 700 | — | — |
| J0177 | Injection, aflibercept hd, 1 mg | 1 MG | $290.902 | 16 | — | yes |
| J0178 | Injection, aflibercept, 1 mg | 1 MG | $722.251 | 4 | — | yes |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 1 MG | $360.439 | 12 | — | yes |
| J0180 | Injection, agalsidase beta, 1 mg | 1 MG | $230.54 | 140 | — | — |
| J0185 | Injection, aprepitant, 1 mg | 1 MG | $1.624 | 130 | — | — |
| J0202 | Injection, alemtuzumab, 1 mg | 1 MG | $2,506.20 | 12 | — | yes |
| J0206 | Injection, allopurinol sodium, 1 mg | 1 MG | $4.292 | 1000 | — | — |
| J0217 | Injection, velmanase alfa-tycv, 1 mg | 1 MG | $479.191 | 150 | — | — |
| J0218 | Injection, olipudase alfa-rpcp, 1 mg | 1 MG | $404.784 | 460 | — | — |
| J0219 | Injection, avalglucosidase alfa-ngpt, 4 mg | 4 MG | $83.816 | 750 | — | — |
| J0221 | Injection, alglucosidase alfa, (lumizyme), 10 mg | 10 MG | $211.056 | 250 | — | — |
| J0222 | Injection, patisiran, 0.1 mg | 0.1 MG | $101.181 | 300 | — | — |
| J0223 | Injection, givosiran, 0.5 mg | 0.5 MG | $120.744 | 756 | — | — |
| J0224 | Injection, lumasiran, 0.5 mg | 0.5 MG | $336.64 | 945 | — | — |
| J0225 | Injection, vutrisiran, 1 mg | 1 MG | $5,008.939 | 25 | — | — |
| J0248 | Injection, remdesivir, 1 mg | 1 MG | $7.511 | 200 | — | — |
| J0256 | Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg | 10 MG | $5.077 | 1600 | — | — |
| J0257 | Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg | 10 MG | $5.64 | 1400 | — | — |
| J0278 | Injection, amikacin sulfate, 100 mg | 100 MG | $0.612 | 15 | — | — |
| J0280 | Injection, aminophyllin, up to 250 mg | 250 MG | $10.757 | 7 | — | yes |
| J0281 | Injection, aminocaproic acid, 1 gram | 1 GM | $1.738 | 30 | — | — |
| J0282 | Injection, amiodarone hydrochloride, 30 mg | 30 MG | $0.384 | 35 | — | — |
| J0283 | Injection, amiodarone hydrochloride (nexterone), 30 mg | 30 MG | $2.763 | 35 | — | — |
| J0285 | Injection, amphotericin b, 50 mg | 50 MG | $42.474 | 5 | — | — |
| J0289 | Injection, amphotericin b liposome, 10 mg | 10 MG | $17.851 | 50 | — | — |
| J0290 | Injection, ampicillin sodium, 500 mg | 500 MG | $0.619 | 24 | — | — |
| J0291 | Injection, plazomicin, 5 mg | 5 MG | $3.519 | 500 | — | — |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 1.5 GM | $1.457 | 12 | — | — |
| J0348 | Injection, anidulafungin, 1 mg | 1 MG | $0.452 | 200 | — | — |
| J0349 | Injection, rezafungin, 1 mg | 1 MG | $11.182 | 400 | — | — |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 20 MG | $3.344 | 2 | — | — |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | 1 MG | $7.456 | 400 | — | — |
| J0402 | Injection, aripiprazole (abilify asimtufii), 1 mg | 1 MG | $6.185 | 960 | — | — |
| J0456 | Injection, azithromycin, 500 mg | 500 MG | $2.571 | 4 | — | — |
| J0457 | Injection, aztreonam, 100 mg | 100 MG | $2.299 | 80 | — | — |
| J0458 | Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg) | 10 MG | $1.756 | — | — | — |
| J0461 | Injection, atropine sulfate, 0.01 mg | 0.01 MG | $0.104 | 200 | — | yes |
| J0462 | Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg | 0.01 MG | $0.129 | — | — | — |
| J0463 | Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg | 0.01 MG | $0.02 | — | — | — |
| J0475 | Injection, baclofen, 10 mg | 10 MG | $186.996 | 8 | — | — |
| J0476 | Injection, baclofen, 50 mcg for intrathecal trial | 50 MCG | $46.539 | 2 | — | — |
| J0480 | Injection, basiliximab, 20 mg | 20 MG | $4,917.63 | 1 | — | — |
| J0485 | Injection, belatacept, 1 mg | 1 MG | $3.883 | 1500 | — | — |
| J0490 | Injection, belimumab, 10 mg | 10 MG | $58.333 | 160 | — | — |
| J0491 | Injection, anifrolumab-fnia, 1 mg | 1 MG | $18.461 | 300 | — | — |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 20 MG | $12.061 | 4 | — | — |
| J0515 | Injection, benztropine mesylate, per 1 mg | 1 MG | $12.262 | 3 | — | — |
| J0517 | Injection, benralizumab, 1 mg | 1 MG | $165.08 | 30 | — | — |
| J0528 | Injection, fosfomycin disodium, 20 mg | 20 MG | $0.633 | — | — | — |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | 100,000 UNITS | $19.523 | 24 | — | — |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 100,000 UNITS | $25.612 | 24 | — | — |
| J0577 | Injection, buprenorphine extended-release (brixadi), less than or equal to 7 | Less than or equal to 7 days of therapy | $433.167 | 1 | — | — |
| J0578 | Injection, buprenorphine extended release (brixadi), greater than 7 days and up | Greater than 7 days and up to 28 days of therapy | $1,732.667 | 1 | — | — |
| J0582 | Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg | 1 MG | $0.168 | — | — | — |
| J0583 | Injection, bivalirudin, 1 mg | 1 MG | $0.165 | 250 | — | — |
| J0584 | Injection, burosumab-twza 1 mg | 1 MG | $516.85 | 90 | — | — |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1 UNIT | $6.514 | 800 | — | yes |
| J0586 | Injection, abobotulinumtoxina, 5 units | 5 Unit | $8.937 | 300 | — | yes |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | 100 UNITS | $13.301 | 300 | — | yes |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | 1 UNIT | $5.262 | 600 | — | yes |
| J0589 | Injection, daxibotulinumtoxina-lanm, 1 unit | 1 UNIT | $3.252 | 300 | — | yes |
| J0592 | Injection, buprenorphine hydrochloride, 0.1 mg | 0.1 MG | $4.698 | 6 | — | — |
| J0593 | Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug | 1 mg | $88.34 | 300 | — | — |
| J0594 | injection, busulfan, 1 mg | 1 MG | $0.839 | 320 | — | — |
| J0595 | Injection, butorphanol tartrate, 1 mg | 1 MG | $11.316 | 8 | — | — |
| J0596 | Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units | 10 UNITS | $37.81 | 840 | — | — |
| J0597 | Injection, c-1 esterase inhibitor (human), berinert, 10 units | 10 UNITS | $79.329 | 250 | — | — |
| J0598 | Injection, c-1 esterase inhibitor (human), cinryze, 10 units | 10 UNITS | $67.065 | 100 | — | — |
| J0600 | Injection, edetate calcium disodium, up to 1000 mg | 1000 MG | $6,273.865 | 3 | — | — |
| J0612 | Injection, calcium gluconate, not otherwise specified, 10 mg | 10 MG | $0.024 | 800 | — | — |
| J0613 | Injection, calcium gluconate (wg critical care), not therapeutically equivalent | 10 MG | $0.041 | 800 | — | — |
| J0614 | Injection, treosulfan, 50 mg | 50 MG | $32.33 | 600 | — | — |
| J0616 | Injection, metoprolol tartrate, 1 mg | 1 MG | $0.14 | 15 | — | — |
| J0637 | Injection, caspofungin acetate, 5 mg | 5 MG | $2.463 | 20 | — | — |
| J0638 | Injection, canakinumab, 1 mg | 1 MG | $156.953 | 300 | — | — |
| J0641 | Injection, levoleucovorin, not otherwise specified, 0.5 mg | 0.5 MG | $0.053 | 1200 | — | — |
| J0642 | Injection, levoleucovorin (khapzory), 0.5 mg | 0.5 MG | $1.336 | 1200 | — | — |
| J0643 | Injection, leucovorin calcium, not otherwise specified, 1 mg | 1 MG | $0.054 | — | — | — |
| J0644 | Injection, leucovorin calcium (avyxa), 1 mg | 1 MG | $2.625 | — | — | — |
| J0650 | Injection, levothyroxine sodium, not otherwise specified, 10 mcg | 10 MCG | $6.581 | 100 | — | — |
| J0651 | Injection, levothyroxine sodium (fresenius kabi), not therapeutically | 10 MCG | $7.079 | 100 | — | — |
| J0652 | Injection, levothyroxine sodium (hikma), not therapeutically equivalent to | 10 MCG | $6.315 | 100 | — | — |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0.5 MG | $0.01 | — | — | — |
| J0666 | Injection, bupivacaine liposome, 1 mg | 1 MG | $1.426 | 266 | — | — |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 10 ML | $4.367 | 10 | 1548 | — |
| J0681 | Injection, ceftobiprole medocaril sodium, 3 mg | 3 MG | $1.098 | — | — | — |
| J0687 | Injection, cefazolin sodium (wg critical care), not therapeutically equivalent | 500 MG | $0.663 | 16 | — | — |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, | 500 MG | $0.829 | 16 | — | — |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, | 500 MG | $1.281 | 16 | — | — |
| J0690 | Injection, cefazolin sodium, 500 mg | 500 MG | $0.781 | 16 | — | — |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 500 MG | $1.292 | 12 | — | — |
| J0694 | Injection, cefoxitin sodium, 1 gm | 1 GM | $5.416 | 8 | — | — |
| J0695 | Injection, ceftolozane 50 mg and tazobactam 25 mg | 75mg (50mg cft/25mg taz) | $10.015 | 60 | — | — |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 250 MG | $0.39 | 16 | — | — |
| J0697 | Injection, sterile cefuroxime sodium, per 750 mg | 750 MG | $2.106 | 4 | — | — |
| J0699 | Injection, cefiderocol, 10 mg | 10 mg | $2.564 | 600 | — | — |
| J0701 | Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to | 500 MG | $6.096 | 12 | — | — |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 3 MG & 3 MG | $7.175 | 18 | — | yes |
| J0703 | Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to | 500 MG | $4.748 | 12 | — | — |
| J0712 | Injection, ceftaroline fosamil, 10 mg | 10 MG | $4.008 | 120 | — | — |
| J0713 | Injection, ceftazidime, per 500 mg | 500 MG | $1.549 | 12 | — | — |
| J0714 | Injection, ceftazidime and avibactam, 0.5 g/0.125 g | .625 GM | $109.454 | 12 | — | — |
| J0716 | Injection, centruroides immune f(ab)2, up to 120 milligrams | UP TO 120MG | $5,449.649 | 4 | — | — |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug | 1 MG | $3.14 | 400 | — | — |
| J0725 | Injection, chorionic gonadotropin, per 1,000 usp units | 1000 UNITS | $14.439 | 10 | — | — |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 1 MG | $14.192 | 50 | — | — |
| J0736 | Injection, clindamycin phosphate, 300 mg | 300 MG | $1.854 | 9 | — | — |
| J0737 | Injection, clindamycin phosphate (baxter), not therapeutically equivalent to | 300 MG | $2.068 | 9 | — | — |
| J0738 | Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv | 1 MG | $16.016 | — | — | — |
| J0739 | Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv | 1 mg | $7.278 | 600 | — | — |
| J0740 | Injection, cidofovir, 375 mg | 375 MG | $522.238 | 2 | — | — |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | 2MG/3MG | $24.649 | 300 | — | — |
| J0742 | Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg | 4 MG-4 MG-2 MG | $2.696 | 500 | — | — |
| J0743 | Injection, cilastatin sodium; imipenem, per 250 mg | 250 MG | $6.796 | 16 | — | — |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 200 MG | $1.93 | 6 | — | — |
| J0750 | Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved | 200 mg/300 mg | $0.451 | — | — | — |
| J0751 | Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved | 200 mg/25 mg | $74.941 | — | — | — |
| J0752 | Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv | 300 MG | $617.946 | — | — | — |
| J0759 | Injection, clevidipine butyrate, 1 mg | 1 MG | $2.95 | 300 | — | — |
| J0770 | Injection, colistimethate sodium, up to 150 mg | 150 MG | $18.051 | 5 | — | — |
| J0775 | Injection, collagenase, clostridium histolyticum, 0.01 mg | 0.01 MG | $81.072 | 180 | — | — |
| J0780 | Injection, prochlorperazine, up to 10 mg | 10 MG | $2.475 | 4 | — | — |
| J0791 | Injection, crizanlizumab-tmca, 5 mg | 5 MG | $129.949 | 160 | — | — |
| J0801 | Injection, corticotropin (acthar gel), up to 40 units | 40 UNITS | $3,884.267 | 3 | — | — |
| J0802 | Injection, corticotropin (ani), up to 40 units | up to 40 Units | $3,646.455 | 3 | — | — |
| J0834 | Injection, cosyntropin, 0.25 mg | 0.25 MG | $22.176 | 3 | — | — |
| J0840 | Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram | UP TO 1 GM | $2,044.383 | 6 | — | yes |
| J0841 | Injection, crotalidae immune f(ab')2 (equine), 120 mg | 120 MG | $1,084.909 | 20 | — | — |
| J0850 | Injection, cytomegalovirus immune globulin intravenous (human), per vial | PER VIAL | $1,857.125 | 9 | — | yes |
| J0870 | Injection, imetelstat, 1 mg | 1 MG | $59.355 | 1081 | — | — |
| J0871 | Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg | 1 MG | $0.541 | — | — | — |
| J0872 | Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent | 1 MG | $0.06 | 1050 | — | — |
| J0873 | Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or | 1 MG | $0.048 | 1000 | — | — |
| J0874 | Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg | 1 MG | $0.062 | 1000 | — | — |
| J0875 | Injection, dalbavancin, 5 mg | 5 MG | $9.439 | 300 | — | — |
| J0877 | Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg | 1 MG | $0.022 | 1000 | — | — |
| J0878 | Injection, daptomycin, 1 mg | 1 MG | $0.027 | 1000 | — | — |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 1 MCG | $3.081 | 500 | — | yes |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 1 MCG | $3.081 | 300 | — | yes |
| J0883 | Injection, argatroban, 1 mg (for non-esrd use) | 1 MG | $0.772 | 1125 | — | — |
| J0884 | Injection, argatroban, 1 mg (for esrd on dialysis) | 1 MG | $0.772 | 1125 | — | — |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 1000 UNITS | $6.669 | 60 | — | yes |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1 MCG | $1.196 | 360 | — | yes |
| J0888 | Injection, epoetin beta, 1 microgram, (for non esrd use) | 1 MCG | $1.196 | 360 | — | yes |
| J0894 | Injection, decitabine, 1 mg | 1 MG | $1.098 | 100 | — | — |
| J0895 | Injection, deferoxamine mesylate, 500 mg | 500 MG | $8.777 | 12 | — | — |
| J0896 | Injection, luspatercept-aamt, 0.25 mg | 0.25 MG | $43.484 | 1100 | — | — |
| J0897 | Injection, denosumab, 1 mg | 1 MG | $29.856 | 120 | — | yes |
| J0898 | Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 | 1 MG | $1.206 | — | — | — |
| J0899 | Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 | 1 MG | $1.206 | — | — | — |
| J0901 | Vadadustat, oral, 1 mg (for esrd on dialysis) | 1 MG | $0.125 | 600 | — | — |
| J1000 | Injection, depo-estradiol cypionate, up to 5 mg | 5 MG | $53.805 | 1 | — | — |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 1 MG | $0.123 | 160 | — | yes |
| J1071 | Injection, testosterone cypionate, 1 mg | 1 MG | $0.023 | 400 | — | yes |
| J1072 | Injection, testosterone cypionate (azmiro), 1 mg | 1 MG | $1.301 | 400 | — | yes |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 0.1 MG | $87.902 | 8 | — | — |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1 MG | $0.099 | 120 | — | yes |
| J1110 | Injection, dihydroergotamine mesylate, per 1 mg | 1 MG | $56.507 | 3 | — | — |
| J1120 | Injection, acetazolamide sodium, up to 500 mg | 500 MG | $23.951 | 2 | — | — |
| J1160 | Injection, digoxin, up to 0.5 mg | 0.5 MG | $3.809 | 2 | — | — |
| J1162 | Injection, digoxin immune fab (ovine), per vial | PER VIAL | $5,711.373 | 1 | — | — |
| J1163 | Injection, diltiazem hydrochloride, 0.5 mg | 0.5 MG | $0.027 | 900 | — | — |
| J1164 | Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg | 0.5 MG | $0.176 | — | — | — |
| J1165 | Injection, phenytoin sodium, per 50 mg | 50 MG | $0.513 | 50 | — | — |
| J1171 | Injection, hydromorphone, 0.1 mg | 0.1 MG | $0.224 | 240 | — | — |
| J1190 | Injection, dexrazoxane hydrochloride, per 250 mg | 250 MG | $30.832 | 8 | — | — |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 50 MG | $0.855 | 8 | — | — |
| J1201 | Injection, cetirizine hydrochloride, 0.5 mg | 0.5 MG | $17.073 | 20 | — | — |
| J1203 | Injection, cipaglucosidase alfa-atga, 5 mg | 5 MG | $96.491 | 630 | — | — |
| J1205 | Injection, chlorothiazide sodium, per 500 mg | 500 MG | $63.398 | 4 | — | — |
| J1212 | Injection, dmso, dimethyl sulfoxide, 50%, 50 ml | 50 ML | $748.813 | 1 | — | — |
| J1230 | Injection, methadone hcl, up to 10 mg | 10 MG | $10.498 | 3 | — | — |
| J1240 | Injection, dimenhydrinate, up to 50 mg | 50 MG | $9.394 | 6 | — | — |
| J1245 | Injection, dipyridamole, per 10 mg | 10 MG | $8.41 | 10 | — | yes |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg | 250 MG | $8.875 | 2 | — | yes |
| J1265 | Injection, dopamine hcl, 40 mg | 40 MG | $0.823 | 20 | — | — |
| J1270 | Injection, doxercalciferol, 1 mcg | 1 MCG | $0.33 | 8 | — | — |
| J1271 | Injection, doxycycline hyclate, 1 mg | 1 MG | $0.081 | 300 | — | — |
| J1289 | Injection, narsoplimab-wuug, 1 mg | 1 MG | $105.441 | — | — | — |
| J1290 | Injection, ecallantide, 1 mg | 1 MG | $599.616 | 30 | — | — |
| J1299 | Injection, eculizumab, 2 mg | 2 MG | $43.763 | 600 | — | yes |
| J1301 | Injection, edaravone, 1 mg | 1 MG | $6.375 | 60 | — | — |
| J1302 | Injection, sutimlimab-jome, 10 mg | 10 MG | $20.133 | 770 | — | — |
| J1303 | Injection, ravulizumab-cwvz, 10 mg | 10 MG | $226.454 | 360 | — | — |
| J1304 | Injection, tofersen, 1 mg | 1 MG | $164.812 | 100 | — | — |
| J1305 | Injection, evinacumab-dgnb, 5mg | 5 MG | $202.574 | 480 | — | — |
| J1306 | Injection, inclisiran, 1 mg | 1 MG | $12.897 | 284 | — | — |
| J1307 | Injection, crovalimab-akkz, 10 mg | 10 MG | $551.512 | 170 | — | — |
| J1308 | Injection, famotidine, 0.25 mg | 0.25 MG | $0.009 | 160 | — | — |
| J1322 | Injection, elosulfase alfa, 1 mg | 1 MG | $320.781 | 150 | — | — |
| J1323 | Injection, elranatamab-bcmm, 1 mg | 1 MG | $191.312 | 76 | — | — |
| J1325 | Injection, epoprostenol, 0.5 mg | 0.5 MG | $17.247 | 1 | — | — |
| J1326 | Injection, zolbetuximab-clzb, 2 mg | 2 MG | $33.919 | 1200 | — | — |
| J1335 | Injection, ertapenem sodium, 500 mg | 500 MG | $5.826 | 2 | — | — |
| J1364 | Injection, erythromycin lactobionate, per 500 mg | 500 MG | $160.427 | 2 | — | — |
| J1380 | Injection, estradiol valerate, up to 10 mg | 10 MG | $7.693 | 4 | — | — |
| J1410 | Injection, estrogen conjugated, per 25 mg | 25 MG | $402.131 | 4 | — | — |
| J1430 | Injection, ethanolamine oleate, 100 mg | 100 MG | $533.768 | 10 | — | — |
| J1434 | Injection, fosaprepitant (focinvez), 1 mg | 1 MG | $2.225 | 150 | — | — |
| J1437 | Injection, ferric derisomaltose, 10 mg | 10 MG | $21.877 | 100 | — | — |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 1 MG | $1.121 | 1000 | — | — |
| J1440 | Fecal microbiota, live - jslm, 1 ml | 1 ML | $65.826 | 150 | — | — |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 1 MCG | $0.994 | 1500 | — | yes |
| J1447 | Injection, tbo-filgrastim, 1 microgram | 1 MCG | $0.279 | 960 | — | yes |
| J1448 | Injection, trilaciclib, 1mg | 1 MG | $6.001 | 900 | — | — |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 0.1 MG | $37.421 | 132 | — | yes |
| J1450 | Injection fluconazole, 200 mg | 200 MG | $5.654 | 4 | — | — |
| J1453 | Injection, fosaprepitant, 1 mg | 1 MG | $0.114 | 150 | — | — |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 0.25 MG | $479.902 | 1 | — | — |
| J1455 | Injection, foscarnet sodium, per 1000 mg | 1000 MG | $6.734 | 18 | — | — |
| J1456 | Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg | 1 MG | $0.036 | 150 | — | — |
| J1458 | Injection, galsulfase, 1 mg | 1 MG | $529.58 | 100 | — | — |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., | 500 MG | $48.963 | 300 | — | yes |
| J1460 | Injection, gamma globulin, intramuscular, 1 cc | 1 CC | $48.946 | 10 | 1 | yes |
| J1551 | Injection, immune globulin (cutaquig), 100 mg | 100 MG | $14.172 | 1600 | — | yes |
| J1552 | Injection, immune globulin (alyglo), 500 mg | 500 MG | $120.04 | 1200 | — | yes |
| J1553 | Injection, immune globulin (yimmugo), 100 mg | 100 MG | $21.664 | — | — | yes |
| J1554 | Injection, immune globulin (asceniv), 500 mg | 500 MG | $508.454 | 240 | — | yes |
| J1555 | Injection, immune globulin (cuvitru), 100 mg | 100 MG | $17.994 | 480 | — | yes |
| J1556 | Injection, immune globulin (bivigam), 500 mg | 500 MG | $80.791 | 240 | — | yes |
| J1557 | Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., | 500 MG | $62.299 | 300 | — | yes |
| J1558 | Injection, immune globulin (xembify), 100 mg | 100 MG | $15.20 | 480 | — | yes |
| J1559 | Injection, immune globulin (hizentra), 100 mg | 100 MG | $14.786 | 2400 | — | yes |
| J1560 | Injection, gamma globulin, intramuscular, over 10 cc | 10 CC | $118.153 | 1 | — | yes |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., | 500 MG | $48.022 | 360 | — | yes |
| J1566 | Injection, immune globulin, intravenous, lyophilized (e.g., powder), not | 500 MG | $82.756 | 300 | — | yes |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., | 500 MG | $47.133 | 300 | — | yes |
| J1569 | Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg | 500 MG | $49.495 | 400 | — | yes |
| J1570 | Injection, ganciclovir sodium, 500 mg | 500 MG | $29.336 | 4 | — | — |
| J1571 | Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml | 0.5 ML | $71.585 | 20 | — | yes |
| J1573 | Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml | 0.5 ML | $71.585 | 130 | — | yes |
| J1575 | Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin | 100 MG | $19.293 | 3000 | — | yes |
| J1576 | Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., | 500 MG | $70.25 | 600 | — | yes |
| J1577 | Injection, immune globulin (qivigy), 100 mg | 100 MG | $29.28 | — | — | yes |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 80 MG | $1.849 | 9 | — | — |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0.1 MG | $0.33 | 18 | — | — |
| J1597 | Injection, glycopyrrolate (glyrx-pf), 0.1 mg | 0.1 MG | $1.272 | 8 | — | — |
| J1598 | Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to | 0.1 MG | $1.904 | 12 | — | — |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 1 MG | $10.978 | 300 | — | — |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 1 MG | $105.492 | 2 | — | — |
| J1611 | Injection, glucagon hydrochloride (fresenius kabi), not therapeutically | 1 MG | $134.892 | 2 | — | — |
| J1612 | Injection, glucagon (gvoke), 0.01 mg | 0.01 MG | $1.799 | — | — | — |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 100 MCG | $0.16 | 30 | — | — |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 0.1 MG | $2.907 | 100 | — | — |
| J1628 | Injection, guselkumab, 1 mg | 1 MG | $66.998 | 200 | — | — |
| J1630 | Injection, haloperidol, up to 5 mg | 5 MG | $0.632 | 5 | — | — |
| J1631 | Injection, haloperidol decanoate, per 50 mg | 50 MG | $4.847 | 9 | — | — |
| J1640 | Injection, hemin, 1 mg | 1 MG | $36.05 | 672 | — | — |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 10 UNITS | $0.018 | 100 | 274 | — |
| J1643 | Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, | 1000 UNITS | $2.248 | 40 | — | — |
| J1644 | Injection, heparin sodium, per 1000 units | 1000 UNITS | $0.201 | 40 | 299 | — |
| J1645 | Injection, dalteparin sodium, per 2500 iu | 2500 IU | $45.668 | 10 | — | — |
| J1650 | Injection, enoxaparin sodium, 10 mg | 10 MG | $0.497 | 30 | — | — |
| J1652 | Injection, fondaparinux sodium, 0.5 mg | 0.5 MG | $0.798 | 20 | — | — |
| J1670 | Injection, tetanus immune globulin, human, up to 250 units | 250 UNITS | $600.635 | 1 | — | yes |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 100 MG | $23.149 | 10 | — | — |
| J1737 | Injection, meloxicam (azurity), 1 mg | 1 MG | $1.06 | 30 | — | — |
| J1740 | Injection, ibandronate sodium, 1 mg | 1 MG | $43.68 | 3 | — | yes |
| J1741 | Injection, ibuprofen, 100 mg | 100 MG | $3.268 | 8 | — | — |
| J1743 | Injection, idursulfase, 1 mg | 1 MG | $572.171 | 66 | — | — |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 10 MG | $29.856 | 150 | — | yes |
| J1746 | Injection, ibalizumab-uiyk, 10 mg | 10 MG | $79.997 | 200 | — | — |
| J1747 | Injection, spesolimab-sbzo, 1 mg | 1 MG | $65.728 | 900 | — | — |
| J1749 | Injection, iloprost, 0.1 mcg | 0.1 MCG | $5.651 | 2000 | — | — |
| J1750 | Injection, iron dextran, 50 mg | 50 MG | $19.005 | 45 | — | — |
| J1756 | Injection, iron sucrose, 1 mg | 1 MG | $0.224 | 500 | — | — |
| J1786 | Injection, imiglucerase, 10 units | 10 UNITS | $43.203 | 680 | — | — |
| J1790 | Injection, droperidol, up to 5 mg | up to 5 MG | $5.348 | 2 | — | — |
| J1805 | Injection, esmolol hydrochloride, 10 mg | 10 MG | $0.246 | — | — | — |
| J1806 | Injection, esmolol hydrochloride (wg critical care), not therapeutically | 10 MG | $0.196 | — | — | — |
| J1808 | Injection, folic acid, 0.1 mg | 0.1 MG | $0.053 | 150 | — | — |
| J1809 | Injection, fosdenopterin, 0.1 mg | 0.1 MG | $17.736 | — | — | — |
| J1811 | Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units | 50 UNITS | $1.181 | — | — | — |
| J1813 | Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 | 50 UNITS | $3.903 | — | — | — |
| J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | 50 UNITS | $3.116 | 0 | — | — |
| J1823 | Injection, inebilizumab-cdon, 1 mg | 1 MG | $511.573 | 300 | — | — |
| J1836 | Injection, metronidazole, 10 mg | 10 MG | $0.034 | 400 | — | — |
| J1837 | Injection, posaconazole, 1 mg | 1 MG | $0.385 | 600 | — | — |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 15 MG | $0.569 | 8 | — | — |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 5 MG | $0.588 | — | — | — |
| J1921 | Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to | 5 MG | $0.874 | — | — | — |
| J1930 | Injection, lanreotide, 1 mg | 1 MG | $41.688 | 120 | — | — |
| J1931 | Injection, laronidase, 0.1 mg | 0.1 MG | $41.498 | 609 | — | — |
| J1932 | Injection, lanreotide, (cipla), 1 mg | 1 MG | $20.33 | 120 | — | — |
| J1938 | Injection, furosemide, 1 mg | 1 MG | $0.018 | 5360 | — | — |
| J1939 | Injection, bumetanide, 0.5 mg | 0.5 MG | $0.493 | 24 | — | — |
| J1943 | Injection, aripiprazole lauroxil, (aristada initio), 1 mg | 1 MG | $3.459 | 675 | — | — |
| J1944 | Injection, aripiprazole lauroxil, (aristada), 1 mg | 1 MG | $3.55 | 1064 | — | — |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | 3.75 MG | $1,799.052 | 12 | — | yes |
| J1951 | Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg | 0.25 MG | $141.696 | 180 | — | — |
| J1952 | Leuprolide injectable, camcevi, 1 mg | 1 mg | $36.373 | 42 | — | yes |
| J1954 | Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg | 7.5 MG | $683.86 | 3 | — | yes |
| J1955 | Injection, levocarnitine, per 1 gm | 1 GM | $24.375 | 11 | — | — |
| J1956 | Injection, levofloxacin, 250 mg | 250 MG | $2.565 | 4 | — | — |
| J1957 | Injection, levetiracetam, 5 mg | 5 MG | $0.013 | — | — | — |
| J1958 | Injection, levetiracetam in sodium chloride, 5 mg | 5 MG | $0.033 | — | — | — |
| J1961 | Injection, lenacapavir (only for use as hiv treatment), 1 mg | 1 MG | $22.937 | — | — | — |
| J2002 | Injection, lidocaine hcl in 5% dextrose, 1 mg | 1 MG | $0.003 | 2000 | 7 | — |
| J2010 | Injection, lincomycin hcl, up to 300 mg | 300 MG | $3.69 | 10 | — | — |
| J2020 | Injection, linezolid, 200 mg | 200 MG | $2.431 | 6 | — | — |
| J2021 | Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg | 200 MG | $31.611 | 6 | — | — |
| J2060 | Injection, lorazepam, 2 mg | 2 MG | $2.197 | 4 | — | — |
| J2151 | Injection, mannitol, 250 mg | 250 MG | $0.112 | — | — | — |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 100 MG | $9.652 | 4 | — | — |
| J2182 | Injection, mepolizumab, 1 mg | 1 MG | $32.181 | 300 | — | — |
| J2183 | Injection, meropenem (wg critical care), not therapeutically equivalent to | 100 MG | $1.339 | 60 | — | — |
| J2184 | Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg | 100 MG | $1.921 | 60 | — | — |
| J2185 | Injection, meropenem, 100 mg | 100 MG | $0.358 | 60 | — | — |
| J2210 | Injection, methylergonovine maleate, up to 0.2 mg | 0.2 MG | $22.117 | 1 | — | — |
| J2246 | Injection, micafungin in sodium (baxter), not therapeutically equivalent to | 1 MG | $0.334 | 150 | — | — |
| J2247 | Injection, micafungin sodium (par pharm) not thereapeutically equivalent to | 1 MG | $0.219 | 150 | — | — |
| J2248 | Injection, micafungin sodium, 1 mg | 1 MG | $0.203 | 150 | — | — |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1 MG | $0.167 | 22 | — | — |
| J2251 | Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically | 1 MG | $0.078 | 22 | — | — |
| J2260 | Injection, milrinone lactate, 5 mg | 5 MG | $1.143 | 4 | — | — |
| J2267 | Injection, mirikizumab-mrkz, 1 mg | 1 MG | $32.584 | 900 | — | — |
| J2270 | Injection, morphine sulfate, up to 10 mg | 10 MG | $7.259 | 9 | — | — |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to | 10 MG | $9.406 | 9 | — | — |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, | 10 MG | $16.044 | 250 | — | yes |
| J2277 | Injection, motixafortide, 0.25 mg | 0.25 MG | $26.479 | 750 | — | — |
| J2278 | Injection, ziconotide, 1 microgram | 1 MCG | $10.656 | 1000 | — | yes |
| J2280 | Injection, moxifloxacin, 100 mg | 100 MG | $8.744 | 4 | — | — |
| J2281 | Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to | 100 MG | $6.641 | 4 | — | — |
| J2290 | Injection, nafcillin sodium, 20 mg | 20 MG | $0.047 | 300 | — | — |
| J2291 | Injection, nafcillin sodium (baxter), 20 mg | 20 MG | $0.135 | — | — | — |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | 10 MG | $4.071 | 4 | — | — |
| J2305 | Injection, nitroglycerin, 5 mg | 5 MG | $1.542 | — | — | — |
| J2312 | Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg | 0.01 MG | $0.076 | 1000 | — | — |
| J2315 | Injection, naltrexone, depot form, 1 mg | 1 MG | $4.537 | 380 | — | — |
| J2323 | Injection, natalizumab, 1 mg | 1 MG | $23.927 | 300 | — | — |
| J2327 | Injection, risankizumab-rzaa, intravenous, 1 mg | 1 MG | $14.011 | 1200 | — | — |
| J2329 | Injection, ublituximab-xiiy, 1mg | 1 MG | $71.089 | — | — | — |
| J2350 | Injection, ocrelizumab, 1 mg | 1 MG | $60.689 | 600 | — | — |
| J2351 | Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq | 1 MG | $47.287 | 920 | — | — |
| J2353 | Injection, octreotide, depot form for intramuscular injection, 1 mg | 1 MG | $211.321 | 60 | — | yes |
| J2354 | Injection, octreotide, non-depot form for subcutaneous or intravenous | 25 MCG | $0.574 | 60 | — | — |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 1 MG | $17.839 | 210 | — | — |
| J2357 | Injection, omalizumab, 5 mg | 5 MG | $45.687 | 120 | — | yes |
| J2358 | Injection, olanzapine, long-acting, 1 mg | 1 MG | $3.202 | 405 | — | — |
| J2359 | Injection, olanzapine, 0.5 mg | 0.5 MG | $0.615 | 60 | — | — |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 60 MG | $6.274 | 2 | — | — |
| J2361 | Injection, depemokimab-ulaa, 1 mg | 1 MG | $275.391 | — | — | — |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 20 MCG | $0.002 | — | — | — |
| J2372 | Injection, phenylephrine hydrochloride (biorphen), 20 micrograms | 20 MCG | $0.162 | — | — | — |
| J2373 | Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms | 20 MCG | $0.136 | — | — | — |
| J2374 | Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml | 0.1 ML | $28.804 | — | — | — |
| J2401 | Injection, chloroprocaine hydrochloride, per 1 mg | 1 MG | $0.045 | 1000 | — | — |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 1 MG | $0.721 | 1600 | — | — |
| J2404 | Injection, nicardipine, 0.1 mg | 0.1 MG | $0.057 | 3600 | — | — |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1 MG | $0.084 | 64 | — | — |
| J2406 | Injection, oritavancin (kimyrsa), 10 mg | 10 MG | $44.392 | 120 | — | — |
| J2407 | Injection, oritavancin (orbactiv), 10 mg | 10 MG | $29.811 | 120 | — | — |
| J2425 | Injection, palifermin, 50 micrograms | 50 MCG | $38.839 | 125 | — | — |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 1 MG | $15.437 | 1560 | — | — |
| J2427 | Injection, paliperidone palmitate extended release (invega hafyera, or invega | 1MG | $13.246 | 1560 | — | — |
| J2428 | Injection, paliperidone palmitate extended release (erzofri), 1 mg | 1 MG | $15.587 | 351 | — | — |
| J2430 | Injection, pamidronate disodium, per 30 mg | 30 MG | $11.306 | 3 | — | yes |
| J2468 | Injection, palonosetron hydrochloride (posfrea), 25 micrograms | 25 MCG | $54.086 | 10 | — | — |
| J2469 | Injection, palonosetron hcl, 25 mcg | 25 MCG | $0.469 | 60 | — | — |
| J2501 | Injection, paricalcitol, 1 mcg | 1 MCG | $0.891 | 2 | — | — |
| J2502 | Injection, pasireotide long acting, 1 mg | 1 MG | $613.14 | 60 | — | — |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 0.5 MG | $201.241 | 12 | — | yes |
| J2507 | Injection, pegloticase, 1 mg | 1 MG | $4,000.629 | 8 | — | — |
| J2508 | Injection, pegunigalsidase alfa-iwxj, 1 mg | 1 MG | $225.998 | 160 | — | — |
| J2516 | Injection, pentamidine isethionate, 1 mg | 1 MG | $0.482 | 600 | — | — |
| J2540 | Injection, penicillin g potassium, up to 600,000 units | 600000 UNITS | $0.781 | 75 | — | — |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 | 1.125 GM | $1.183 | 16 | — | — |
| J2545 | Pentamidine isethionate, inhalation solution, fda-approved final product, | 300 MG | $67.047 | 1 | — | — |
| J2550 | Injection, promethazine hcl, up to 50 mg | 50 MG | $3.241 | 3 | — | — |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | 120 MG | $23.369 | 1 | — | — |
| J2562 | Injection, plerixafor, 1 mg | 1 MG | $42.943 | 48 | — | — |
| J2596 | Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 | 1 UNIT | $1.712 | 160 | — | — |
| J2597 | Injection, desmopressin acetate, per 1 mcg | 1 MCG | $3.475 | 45 | — | — |
| J2598 | Injection, vasopressin, 1 unit | 1 UNIT | $0.566 | 160 | — | — |
| J2599 | Injection, vasopressin (american regent), not therapeutically equivalent to | 1 UNIT | $0.574 | 160 | — | — |
| J2601 | Injection, vasopressin (baxter), 1 unit | 1 UNIT | $2.328 | 160 | — | — |
| J2675 | Injection, progesterone, per 50 mg | 50 MG | $0.623 | 1 | — | — |
| J2679 | Injection, fluphenazine hcl, 1.25 mg | 1.25 MG | $7.269 | 8 | — | — |
| J2680 | Injection, fluphenazine decanoate, up to 25 mg | 25 MG | $6.174 | 4 | — | — |
| J2690 | Injection, procainamide hcl, up to 1 gm | 1 GM | $394.868 | 4 | — | — |
| J2700 | Injection, oxacillin sodium, up to 250 mg | 250 MG | $0.768 | 48 | — | — |
| J2704 | Injection, propofol, 10 mg | 10 MG | $0.093 | 80 | — | — |
| J2720 | Injection, protamine sulfate, per 10 mg | 10 MG | $1.785 | 5 | — | — |
| J2724 | Injection, protein c concentrate, intravenous, human, 10 iu | 10 UNITS | $15.034 | 3500 | — | — |
| J2760 | Injection, phentolamine mesylate, up to 5 mg | 5 MG | $296.849 | 2 | — | — |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 10 MG | $0.891 | 10 | — | — |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 0.1 MG | $31.322 | 120 | — | yes |
| J2778 | Injection, ranibizumab, 0.1 mg | 0.1 mg | $26.384 | 10 | — | yes |
| J2779 | Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg | 0.1 MG | $73.542 | 200 | — | yes |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1 MG | $135.267 | 30 | — | — |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 0.1 MG | $100.563 | 40 | — | — |
| J2783 | Injection, rasburicase, 0.5 mg | 0.5 MG | $386.628 | 60 | — | — |
| J2785 | Injection, regadenoson, 0.1 mg | 0.1 MG | $2.507 | 4 | — | yes |
| J2786 | Injection, reslizumab, 1 mg | 1 MG | $11.907 | 500 | — | — |
| J2788 | Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) | 50 MCG (250 IU) | $27.653 | 1 | — | yes |
| J2789 | Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml | UP TO 2 ML | $41,359.618 | — | — | — |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 300 MCG (1500 IU) | $82.081 | 1 | — | yes |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or | 100 IU | $4.837 | 15 | — | yes |
| J2792 | Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu | 100 IU | $35.395 | 450 | 1 | yes |
| J2794 | Injection, risperidone (risperdal consta), 0.5 mg | 0.5 MG | $10.662 | 100 | — | — |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1 MG | $0.04 | 200 | — | — |
| J2798 | Injection, risperidone, (perseris), 0.5 mg | 0.5 mg | $12.191 | 240 | — | — |
| J2799 | Injection, risperidone (uzedy), 1 mg | 1 MG | $26.227 | 250 | — | — |
| J2800 | Injection, methocarbamol, up to 10 ml | 10 ML | $3.839 | 3 | — | — |
| J2802 | Injection, romiplostim, 1 microgram | 1 MCG | $11.713 | 1500 | — | — |
| J2804 | Injection, rifampin, 1 mg | 1 MG | $0.165 | 1200 | — | — |
| J2805 | Injection, sincalide, 5 micrograms | 5 MCG | $145.638 | 3 | — | — |
| J2820 | Injection, sargramostim (gm-csf), 50 mcg | 50 MCG | $62.47 | 15 | — | yes |
| J2860 | Injection, siltuximab, 10 mg | 10 MG | $178.427 | 170 | — | — |
| J2865 | Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg | 5MG-1MG | $0.034 | 3000 | — | — |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 12.5 MG | $1.956 | 20 | — | — |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 5 MG | $0.255 | 5400 | — | yes |
| J2997 | Injection, alteplase recombinant, 1 mg | 1 MG | $98.416 | 100 | — | — |
| J3000 | Injection, streptomycin, up to 1 gm | 1 GM | $16.407 | 2 | — | — |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0.1 MG | $1.362 | 100 | — | — |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 1 MG | $21.243 | 300 | — | — |
| J3055 | Injection, talquetamab-tgvs, 0.25 mg | 0.25 MG | $77.473 | 480 | — | — |
| J3060 | Injection, taliglucerase alfa, 10 units | 10 UNITS | $42.473 | 760 | — | — |
| J3090 | Injection, tedizolid phosphate, 1 mg | 1 MG | $2.062 | 200 | — | — |
| J3095 | Injection, telavancin, 10 mg | 10 MG | $8.149 | 150 | — | — |
| J3101 | Injection, tenecteplase, 1 mg | 1 MG | $230.742 | 50 | — | — |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 1 MG | $1.00 | 2 | — | — |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 1 MG | $12.792 | 210 | — | — |
| J3121 | Injection, testosterone enanthate, 1 mg | 1 MG | $0.052 | 400 | — | yes |
| J3145 | Injection, testosterone undecanoate, 1 mg | 1 MG | $2.203 | 750 | — | yes |
| J3230 | Injection, chlorpromazine hcl, up to 50 mg | 50 MG | $16.802 | 2 | — | — |
| J3240 | Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial | 0.9 MG | $2,155.112 | 1 | — | — |
| J3241 | Injection, teprotumumab-trbw, 10 mg | 10 MG | $381.627 | 500 | — | — |
| J3243 | Injection, tigecycline, 1 mg | 1 MG | $0.479 | 150 | — | — |
| J3245 | Injection, tildrakizumab, 1 mg | 1 MG | $120.965 | 100 | — | — |
| J3246 | Injection, tirofiban hcl, 0.25 mg | 0.25 MG | $2.615 | 1 | — | — |
| J3247 | Injection, secukinumab, intravenous, 1 mg | 1 MG | $18.131 | 1000 | — | — |
| J3250 | Injection, trimethobenzamide hcl, up to 200 mg | 200 MG | $62.418 | 2 | — | — |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | 80 MG | $2.345 | 8 | — | — |
| J3262 | Injection, tocilizumab, 1 mg | 1 MG | $5.325 | 800 | — | — |
| J3263 | Injection, toripalimab-tpzi, 1 mg | 1 MG | $40.658 | 480 | — | — |
| J3268 | Injection, delafloxacin, 1 mg | 1 MG | $0.478 | — | — | — |
| J3285 | Injection, treprostinil, 1 mg | 1 MG | $54.563 | 1 | — | — |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | 1 MG | $47.705 | 72 | — | — |
| J3300 | Injection, triamcinolone acetonide (triesence), preservative free, 1 mg | 1 MG | $17.199 | 80 | — | yes |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 10 MG | $0.787 | 16 | — | yes |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, | 1 MG | $19.159 | 64 | — | — |
| J3315 | Injection, triptorelin pamoate, 3.75 mg | 3.75 MG | $467.059 | 6 | — | yes |
| J3316 | Injection, triptorelin, extended-release, 3.75 mg | 3.75 MG | $3,830.439 | 6 | — | yes |
| J3358 | Ustekinumab, for intravenous injection, 1 mg | 1 MG | $10.249 | 520 | — | — |
| J3360 | Injection, diazepam, up to 5 mg | 5 MG | $5.069 | 6 | — | — |
| J3373 | Injection, vancomycin hydrochloride, 10 mg | 10 MG | $0.032 | 600 | — | — |
| J3374 | Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to | 10 MG | $0.091 | 600 | — | — |
| J3375 | Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent | 10 MG | $0.143 | 600 | — | — |
| J3376 | Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 | 10 MG | $0.016 | 600 | — | — |
| J3379 | Injection, valproate sodium, 5 mg | 5 MG | $0.032 | 2000 | — | — |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 1 MG | $20.949 | 300 | — | — |
| J3385 | Injection, velaglucerase alfa, 100 units | 100 UNITS | $393.929 | 80 | — | — |
| J3396 | Injection, verteporfin, 0.1 mg | 0.1 MG | $11.342 | 150 | — | — |
| J3401 | Beremagene geperpavec-svdt for topical administration, containing nominal 5 x | 0.1 ML | $1,029.469 | 25 | — | — |
| J3402 | Injection, remestemcel-l-rknd, per therapeutic dose | Per Therapeutic Dose | $202,159.938 | — | — | — |
| J3404 | Injection, zopapogene imadenovec-drba suspension, per therapeutic dose | Per Therapeutic Dose | $119,675.512 | — | — | — |
| J3405 | Injection, onasemnogene abeparvovec-brve, per treatment | Per treatment | $2,729,937.922 | — | — | — |
| J3410 | Injection, hydroxyzine hcl, up to 25 mg | 25 MG | $14.113 | 8 | — | — |
| J3411 | Injection, thiamine hcl, 100 mg | 100 MG | $1.486 | 4 | — | — |
| J3415 | Injection, pyridoxine hcl, 100 mg | 100 MG | $15.788 | 6 | — | — |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 1000 MCG | $0.648 | 1 | — | yes |
| J3425 | Injection, hydroxocobalamin, intramuscular, 10 mcg | 10 MCG | $0.007 | 20 | — | yes |
| J3430 | Injection, phytonadione (vitamin k), per 1 mg | 1 MG | $3.989 | 25 | — | — |
| J3465 | Injection, voriconazole, 10 mg | 10 MG | $0.548 | 40 | — | — |
| J3470 | Injection, hyaluronidase, up to 150 units | 150 UNITS | $31.802 | 3 | — | — |
| J3473 | Injection, hyaluronidase, recombinant, 1 usp unit | 1 USP UNIT | $0.364 | 450 | — | — |
| J3475 | Injection, magnesium sulfate, per 500 mg | 500 MG | $0.436 | 20 | — | — |
| J3480 | Injection, potassium chloride, per 2 meq | 2 MEQ | $0.13 | 40 | — | — |
| J3485 | Injection, zidovudine, 10 mg | 10 MG | $1.513 | 160 | — | — |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 10 MG | $5.94 | 4 | — | — |
| J3489 | Injection, zoledronic acid, 1 mg | 1 MG | $17.673 | 5 | — | yes |
| J7030 | Infusion, normal saline solution , 1000 cc | 1000 CC | $2.263 | 5 | — | — |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 500 ML | $1.385 | 6 | — | yes |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 500 ML | $1.265 | 6 | — | — |
| J7050 | Infusion, normal saline solution, 250 cc | 250 CC | $0.717 | 10 | — | — |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 500 ML | $2.082 | 10 | — | — |
| J7070 | Infusion, d5w, 1000 cc | 1000 CC | $3.37 | 4 | — | — |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1000 CC | $2.369 | 4 | — | — |
| J7170 | Injection, emicizumab-kxwh, 0.5 mg | 0.5 MG | $58.114 | 1800 | — | yes |
| J7171 | Injection, adamts13, recombinant-krhn, 10 iu | 10 UNITS | $36.378 | — | — | — |
| J7172 | Injection, marstacimab-hncq, 0.5 mg | 0.5 MG | $50.76 | 2400 | — | — |
| J7173 | Injection, concizumab-mtci, 0.5 mg | 0.5 MG | $84.782 | — | — | — |
| J7174 | Injection, fitusiran, 0.04 mg | 0.04 MG | $133.477 | — | — | — |
| J7175 | Injection, factor x, (human), 1 i.u. | 1 IU | $9.953 | 9000 | — | yes |
| J7177 | Injection, human fibrinogen concentrate (fibryga), 1 mg | 1 MG | $1.219 | 10500 | — | — |
| J7178 | Injection, human fibrinogen concentrate, not otherwise specified, 1 mg | 1 MG | $1.428 | 7700 | — | — |
| J7179 | Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco | 1 IU | $1.826 | 7500 | — | yes |
| J7180 | Injection, factor xiii (antihemophilic factor, human), 1 i.u. | 1 IU | $11.239 | 6000 | — | yes |
| J7181 | Injection, factor xiii a-subunit, (recombinant), per iu | 1 IU | $19.328 | 3850 | — | yes |
| J7182 | Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per | 1 IU | $1.557 | 22000 | — | yes |
| J7183 | Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco | 1 I.U. VWF:RCO | $1.304 | 7500 | — | yes |
| J7185 | Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. | 1 IU | $1.369 | 22000 | — | yes |
| J7186 | Injection, antihemophilic factor viii/von willebrand factor complex (human), | PER FACTOR VIII IU | $1.267 | 7500 | — | yes |
| J7187 | Injection, von willebrand factor complex (humate-p), per iu vwf:rco | 1 IU | $1.531 | 7500 | — | yes |
| J7188 | Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. | 1 IU | $3.236 | 22000 | — | yes |
| J7189 | Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram | 1 MCG | $2.774 | 13000 | — | yes |
| J7190 | Factor viii (antihemophilic factor, human) per i.u. | 1 IU | $1.248 | 22000 | — | yes |
| J7192 | Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise | 1 IU | $1.616 | 22000 | — | yes |
| J7193 | Factor ix (antihemophilic factor, purified, non-recombinant) per i.u. | 1 IU | $1.412 | 4000 | — | yes |
| J7194 | Factor ix, complex, per i.u. | 1 IU | $1.748 | 9000 | — | yes |
| J7195 | Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise | 1 IU | $1.868 | 6000 | — | yes |
| J7197 | Antithrombin iii (human), per i.u. | 1 IU | $4.264 | 6300 | — | yes |
| J7198 | Anti-inhibitor, per i.u. | 1 IU | $2.474 | 6000 | — | yes |
| J7200 | Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu | 1 IU | $1.713 | 20000 | — | yes |
| J7201 | Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. | 1 IU | $3.761 | 9000 | — | yes |
| J7202 | Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. | 1 IU | $5.491 | 11550 | — | yes |
| J7203 | Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, | 1 IU | $4.715 | 12000 | — | yes |
| J7204 | Injection, factor viii, antihemophilic factor (recombinant), (esperoct), | 1 IU | $2.363 | 19500 | — | yes |
| J7205 | Injection, factor viii fc fusion protein (recombinant), per iu | 1 IU | $2.557 | 9750 | — | yes |
| J7207 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. | 1 IU | $2.185 | 22500 | — | yes |
| J7208 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, | 1 IU | $2.744 | 12000 | — | yes |
| J7209 | Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. | 1 IU | $1.179 | 7500 | — | yes |
| J7210 | Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. | 1 IU | $1.612 | 22000 | — | yes |
| J7211 | Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. | 1 IU | $1.574 | 22000 | — | yes |
| J7212 | Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram | 1 MCG | $2.25 | 90000 | — | yes |
| J7213 | Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. | 1 IU | $2.035 | 12000 | — | — |
| J7214 | Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), | 1 IU | $4.656 | 7500 | — | — |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage | 354 MG | $390.523 | 3 | — | — |
| J7311 | Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg | 0.01 MG | $341.131 | 118 | — | — |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 0.1 MG | $202.424 | 14 | — | — |
| J7313 | Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg | 0.01 MG | $516.516 | 38 | — | — |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 1 MG | $6.314 | 120 | — | yes |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 1 MG | $4.231 | 50 | — | yes |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular | per dose | $69.868 | 2 | — | yes |
| J7322 | Hyaluronan or derivative, hymovis or hymovis one, for intra-articular | 1 MG | $17.94 | 64 | — | yes |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | per dose | $103.603 | 2 | — | yes |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | PER DOSE | $116.793 | 2 | — | yes |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular | 1 MG | $6.011 | 96 | — | yes |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | per dose | $524.063 | 2 | — | yes |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | PER DOSE | $626.144 | 2 | — | yes |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 0.1 MG | $0.55 | 336 | — | yes |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 1 MG | $4.207 | 50 | — | yes |
| J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | 1 MG | $3.115 | 40 | — | yes |
| J7332 | Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | 1 MG | $10.188 | 40 | — | yes |
| J7336 | Capsaicin 8% patch, per square centimeter | 1 SQ CM | $3.509 | 1120 | — | — |
| J7340 | Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml | 100 ML | $243.108 | 1 | — | — |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 10 MG | $1.848 | 600 | — | — |
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | 1 MCG | $213.795 | 20 | — | — |
| J7354 | Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 | Per 3.2 mg single-use applicator | $683.472 | 2 | — | — |
| J7355 | Injection, travoprost, intracameral implant, 1 microgram | 1 MCG | $196.804 | 150 | — | — |
| J7356 | Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg | 0.25 MG - 5 MG | $0.702 | 960 | — | — |
| J7402 | Mometasone furoate sinus implant, (sinuva), 10 micrograms | 10 MCG | $11.345 | 270 | — | — |
| J7500 | Azathioprine, oral, 50 mg | 50 MG | $0.103 | 0 | — | — |
| J7502 | Cyclosporine, oral, 100 mg | 100 MG | $1.455 | 0 | — | — |
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | 0.25 MG | $1.863 | 0 | — | — |
| J7504 | Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg | 250 MG | $5,509.072 | 15 | — | — |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 1 MG | $0.162 | 0 | — | — |
| J7508 | Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg | 0.1 MG | $0.604 | 0 | — | — |
| J7509 | Methylprednisolone oral, per 4 mg | 4 MG | $0.128 | 0 | — | — |
| J7510 | Prednisolone oral, per 5 mg | 5 MG | $0.498 | 0 | — | — |
| J7511 | Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg | 25 MG | $1,065.837 | 9 | — | — |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1 MG | $0.004 | 0 | — | — |
| J7515 | Cyclosporine, oral, 25 mg | 25 MG | $0.576 | 0 | — | — |
| J7516 | Injection, cyclosporine, 250 mg | 250 MG | $75.649 | 1 | — | — |
| J7518 | Mycophenolic acid, oral, 180 mg | 180 MG | $0.257 | 0 | — | — |
| J7520 | Sirolimus, oral, 1 mg | 1 MG | $0.609 | 0 | — | — |
| J7521 | Tacrolimus, granules, oral suspension, 0.1 mg | 0.1 MG | $1.328 | 300 | — | — |
| J7524 | Mycophenolate mofetil, oral, 5 mg | 5 MG | $0.002 | — | — | — |
| J7525 | Tacrolimus, parenteral, 5 mg | 5 MG | $242.073 | 2 | — | — |
| J7526 | Injection, mycophenolate mofetil, 5 mg | 5 MG | $0.20 | — | — | — |
| J7527 | Everolimus, oral, 0.25 mg | 0.25 MG | $1.126 | 40 | — | — |
| J7529 | Mycophenolate mofetil, for suspension, oral, 5 mg | 5 MG | $0.034 | — | — | — |
| J7530 | Mycophenolate mofetil (myhibbin), oral suspension, 5 mg | 5 MG | $0.115 | — | — | — |
| J7601 | Ensifentrine, inhalation suspension, fda approved final product, | 3 MG | $52.117 | 2 | — | — |
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, | 15 mcg | $0.542 | 2 | — | — |
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, | 20 MCG | $1.373 | 2 | — | — |
| J7608 | Acetylcysteine, inhalation solution, fda-approved final product, | 1 GM | $6.398 | 3 | — | — |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, | 1 MG | $0.206 | 10 | — | — |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, | 0.5 MG | $0.304 | 10 | — | — |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, | 1 MG | $0.066 | 10 | — | — |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, | 0.5 MG | $0.076 | 10 | — | — |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved | 2.5 MG/0.5 MG | $0.197 | 6 | — | — |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, | 0.5 MG | $0.923 | 2 | — | — |
| J7631 | Cromolyn sodium, inhalation solution, fda-approved final product, | 10 MG | $0.385 | 4 | — | — |
| J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, | 1 MG | $56.806 | 3 | — | — |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, | 1 MG | $0.445 | 3 | — | — |
| J7674 | Methacholine chloride administered as inhalation solution through a nebulizer, | 1 MG | $1.766 | 100 | — | — |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, | 1 MCG | $0.20 | 175 | — | — |
| J7682 | Tobramycin, inhalation solution, fda-approved final product, non-compounded, | 300 MG | $11.404 | 2 | — | — |
| J7686 | Treprostinil, inhalation solution, fda-approved final product, non-compounded, | 1.74 MG | $830.383 | 1 | — | — |
| J8501 | Aprepitant, oral, 5 mg | 5 MG | $2.511 | 0 | — | — |
| J8502 | Injection, aprepitant (aponvie), 1 mg | 1 MG | $1.998 | — | — | — |
| J8515 | Cabergoline, oral, 0.25 mg | 0.25 MG | $0.337 | 0 | — | — |
| J8522 | Capecitabine, oral, 50 mg | 50 MG | $0.029 | — | — | — |
| J8530 | Cyclophosphamide; oral, 25 mg | 25 MG | $1.233 | 0 | — | — |
| J8540 | Dexamethasone, oral, 0.25 mg | 0.25 MG | $0.022 | 0 | — | — |
| J8541 | Dexamethasone (hemady), oral, 0.25 mg | 0.25 MG | $0.375 | — | — | — |
| J8560 | Etoposide; oral, 50 mg | 50 MG | $88.164 | 0 | — | — |
| J8610 | Methotrexate; oral, 2.5 mg | 2.5 MG | $0.157 | 0 | — | — |
| J8611 | Methotrexate (jylamvo), oral, 2.5 mg | 2.5 MG | $18.264 | — | — | — |
| J8612 | Methotrexate (xatmep), oral, 2.5 mg | 2.5 MG | $22.855 | — | — | — |
| J8655 | Netupitant 300 mg and palonosetron 0.5 mg, oral | 0.5 MG | $455.762 | 1 | — | — |
| J8700 | Temozolomide, oral, 5 mg | 5 MG | $0.208 | 0 | — | — |
| J8705 | Topotecan, oral, 0.25 mg | 0.25 mg | $125.461 | 0 | — | — |
| J9000 | Injection, doxorubicin hydrochloride, 10 mg | 10 MG | $3.12 | 20 | — | — |
| J9011 | Injection, datopotamab deruxtecan-dlnk, 1 mg | 1 MG | $52.505 | 600 | — | — |
| J9017 | Injection, arsenic trioxide, 1 mg | 1 MG | $3.837 | 30 | — | — |
| J9021 | Injection, asparaginase, recombinant, (rylaze), 0.1 mg | 0.1 MG | $59.042 | 1500 | — | — |
| J9022 | Injection, atezolizumab, 10 mg | 10 MG | $96.873 | 168 | — | — |
| J9023 | Injection, avelumab, 10 mg | 10 MG | $108.994 | 140 | — | — |
| J9024 | Injection, atezolizumab, 5 mg and hyaluronidase-tqjs | 5 MG | $32.419 | 375 | — | — |
| J9025 | Injection, azacitidine, 1 mg | 1 MG | $0.269 | 300 | — | — |
| J9026 | Injection, tarlatamab-dlle, 1 mg | 1 MG | $1,613.751 | 10 | — | — |
| J9027 | Injection, clofarabine, 1 mg | 1 MG | $15.518 | 100 | — | — |
| J9028 | Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram | 1 MCG | $94.139 | 400 | — | — |
| J9029 | Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose | PER THERAPEUTIC DOSE | $65,200.563 | 1 | — | — |
| J9030 | Bcg live intravesical instillation, 1 mg | 1 MG | $3.532 | 50 | — | yes |
| J9032 | Injection, belinostat, 10 mg | 10 MG | $55.526 | 300 | — | — |
| J9033 | Injection, bendamustine hydrochloride, not otherwise specified, 1 mg | 1 MG | $1.846 | 300 | — | — |
| J9034 | Injection, bendamustine hcl (bendeka), 1 mg | 1 MG | $11.422 | 360 | — | — |
| J9035 | Injection, bevacizumab, 10 mg | 10 MG | $75.492 | 230 | — | yes |
| J9036 | Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg | 1 MG | $9.264 | 360 | — | — |
| J9038 | Injection, axatilimab-csfr, 0.1 mg | 0.1 MG | $56.498 | 360 | — | — |
| J9039 | Injection, blinatumomab, 1 microgram | 1 MCG | $173.047 | 210 | — | — |
| J9040 | Injection, bleomycin sulfate, 15 units | 15 UNITS | $23.12 | 4 | — | — |
| J9041 | Injection, bortezomib, 0.1 mg | 0.1 MG | $2.628 | 35 | — | — |
| J9042 | Injection, brentuximab vedotin, 1 mg | 1 MG | $279.207 | 200 | — | — |
| J9043 | Injection, cabazitaxel, 1 mg | 1 MG | $231.688 | 60 | — | — |
| J9045 | Injection, carboplatin, 50 mg | 50 MG | $3.101 | 22 | — | — |
| J9047 | Injection, carfilzomib, 1 mg | 1 MG | $60.391 | 210 | — | — |
| J9049 | Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg | 0.1 MG | $1.531 | 35 | — | — |
| J9050 | Injection, carmustine, 100 mg | 100 MG | $195.73 | 6 | — | — |
| J9053 | Injection, belantamab mafodotin-blmf, 0.1 mg | 0.1 MG | $36.201 | — | — | — |
| J9054 | Injection, bortezomib (boruzu), 0.1 mg | 0.1 MG | $23.905 | 70 | — | — |
| J9055 | Injection, cetuximab, 10 mg | 10 MG | $80.858 | 150 | — | — |
| J9056 | Injection, bendamustine hydrochloride (vivimusta), 1 mg | 1 MG | $28.614 | 360 | — | — |
| J9060 | Injection, cisplatin, powder or solution, 10 mg | 10 MG | $2.497 | 24 | — | — |
| J9061 | Injection, amivantamab-vmjw, 2 mg | 2 MG | $23.622 | 1050 | — | — |
| J9062 | Injection, amivantamab 5 mg and hyaluronidase-lpuj | 5 MG | $40.492 | — | — | — |
| J9063 | Injection, mirvetuximab soravtansine-gynx, 1 mg | 1 MG | $71.584 | 900 | — | — |
| J9065 | Injection, cladribine, per 1 mg | 1 MG | $7.872 | 100 | — | — |
| J9071 | Injection, cyclophosphamide (auromedics), 5 mg | 5 MG | $0.471 | 1500 | — | — |
| J9072 | Injection, cyclophosphamide (frindovyx), 5 mg | 5 MG | $8.12 | 1500 | — | — |
| J9073 | Injection, cyclophosphamide (dr. reddy's), 5 mg | 5 MG | $0.465 | 1500 | — | — |
| J9074 | Injection, cyclophosphamide (sandoz), 5 mg | 5 MG | $3.238 | 1500 | — | — |
| J9075 | Injection, cyclophosphamide, not otherwise specified, 5 mg | 5 MG | $0.692 | 1500 | — | — |
| J9076 | Injection, cyclophosphamide (baxter), 5 mg | 5 MG | $4.601 | 1500 | — | — |
| J9100 | Injection, cytarabine, 100 mg | 100 MG | $0.853 | 120 | — | — |
| J9118 | Injection, calaspargase pegol-mknl, 10 units | 10 UNIT | $86.179 | 750 | — | — |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 1 MG | $30.825 | 700 | — | — |
| J9120 | Injection, dactinomycin, 0.5 mg | 0.5 MG | $320.899 | 5 | — | — |
| J9130 | Dacarbazine, 100 mg | 100 MG | $3.581 | 24 | — | — |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 10 MG | $57.973 | 180 | — | — |
| J9145 | Injection, daratumumab, 10 mg | 10 MG | $75.228 | 240 | — | — |
| J9150 | Injection, daunorubicin, 10 mg | 10 MG | $26.912 | 12 | — | — |
| J9153 | Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine | 1 MG/2.27 MG | $274.30 | 132 | — | — |
| J9155 | Injection, degarelix, 1 mg | 1 MG | $4.509 | 240 | — | — |
| J9161 | Injection, denileukin diftitox-cxdl, 1 mcg | 1 MCG | $12.826 | 1500 | — | — |
| J9171 | Injection, docetaxel, 1 mg | 1 MG | $0.471 | 300 | — | — |
| J9172 | Injection, docetaxel (docivyx), 1 mg | 1 MG | $46.193 | 300 | — | — |
| J9173 | Injection, durvalumab, 10 mg | 10 MG | $87.658 | 150 | — | — |
| J9174 | Injection, docetaxel (beizray), 1 mg | 1 MG | $46.531 | 320 | — | — |
| J9176 | Injection, elotuzumab, 1 mg | 1 MG | $8.188 | 3000 | — | — |
| J9177 | Injection, enfortumab vedotin-ejfv, 0.25 mg | 0.25 MG | $36.535 | 520 | — | — |
| J9178 | Injection, epirubicin hcl, 2 mg | 2 MG | $1.868 | 150 | — | — |
| J9179 | Injection, eribulin mesylate, 0.1 mg | 0.1 MG | $63.972 | 50 | — | — |
| J9183 | Gemcitabine intravesical system, 225 mg | 225 MG | $73,054.053 | — | — | — |
| J9184 | Injection, gemcitabine hydrochloride (avyxa), 200 mg | 200 MG | $403.465 | 19 | — | — |
| J9185 | Injection, fludarabine phosphate, 50 mg | 50 MG | $177.924 | 2 | — | — |
| J9186 | Injection, etoposide (avyxa), 1 mg | 1 MG | $4.24 | — | — | — |
| J9187 | Injection, etoposide, 1 mg | 1 MG | $0.094 | — | — | — |
| J9191 | Injection, fluorouracil (avyxa), 10 mg | 10 MG | $14.84 | — | — | — |
| J9192 | Injection, fluorouracil, 10 mg | 10 MG | $0.039 | — | — | — |
| J9200 | Injection, floxuridine, 500 mg | 500 MG | $4,389.848 | 5 | — | yes |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 200 MG | $2.734 | 20 | — | — |
| J9203 | Injection, gemtuzumab ozogamicin, 0.1 mg | 0.1 MG | $247.37 | 180 | — | — |
| J9204 | Injection, mogamulizumab-kpkc, 1 mg | 1 MG | $258.536 | 160 | — | — |
| J9205 | Injection, irinotecan liposome, 1 mg | 1 MG | $66.856 | 215 | — | — |
| J9206 | Injection, irinotecan, 20 mg | 20 MG | $1.569 | 42 | — | — |
| J9207 | Injection, ixabepilone, 1 mg | 1 MG | $139.498 | 90 | — | — |
| J9208 | Injection, ifosfamide, 1 gram | 1 GM | $27.905 | 15 | — | — |
| J9209 | Injection, mesna, 200 mg | 200 MG | $1.203 | 55 | — | — |
| J9210 | Injection, emapalumab-lzsg, 1 mg | 1 MG | $391.861 | 1500 | — | — |
| J9211 | Injection, idarubicin hydrochloride, 5 mg | 5 MG | $33.394 | 6 | — | — |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 7.5 MG | $188.849 | 6 | — | yes |
| J9223 | Injection, lurbinectedin, 0.1 mg | 0.1 MG | $215.722 | 120 | — | — |
| J9226 | Histrelin implant (supprelin la), 50 mg | 50 MG | $37,837.548 | 1 | — | — |
| J9227 | Injection, isatuximab-irfc, 10 mg | 10 MG | $89.812 | 150 | — | — |
| J9228 | Injection, ipilimumab, 1 mg | 1 MG | $190.433 | 1100 | — | — |
| J9229 | Injection, inotuzumab ozogamicin, 0.1 mg | 0.1 MG | $2,873.103 | 27 | — | — |
| J9232 | Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg | 1 MG | $0.513 | — | — | — |
| J9245 | Injection, melphalan hydrochloride, not otherwise specified, 50 mg | 50 MG | $90.032 | 9 | — | — |
| J9246 | Injection, melphalan (evomela), 1 mg | 1 MG | $18.569 | 300 | — | — |
| J9248 | Injection, melphalan (hepzato), 1 mg | 1 MG | $797.415 | 250 | — | — |
| J9256 | Injection, nipocalimab-aahu, 3 mg | 3 MG | $32.321 | 1500 | — | — |
| J9260 | Injection, methotrexate sodium, 50 mg | 50 MG | $2.909 | 400 | — | yes |
| J9261 | Injection, nelarabine, 50 mg | 50 MG | $40.872 | 80 | — | — |
| J9263 | Injection, oxaliplatin, 0.5 mg | 0.5 MG | $0.087 | 700 | — | — |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 1 MG | $3.64 | 800 | — | yes |
| J9266 | Injection, pegaspargase, per single dose vial | 1 EA | $29,845.265 | 2 | — | — |
| J9267 | Injection, paclitaxel, 1 mg | 1 MG | $0.108 | 750 | — | yes |
| J9268 | Injection, pentostatin, 10 mg | 10 MG | $2,612.893 | 1 | — | — |
| J9269 | Injection, tagraxofusp-erzs, 10 micrograms | 10 MCG | $357.292 | 200 | — | — |
| J9271 | Injection, pembrolizumab, 1 mg | 1 MG | $62.253 | 400 | — | — |
| J9272 | Injection, dostarlimab-gxly, 10 mg | 10 MG | $250.548 | 100 | — | — |
| J9273 | Injection, tisotumab vedotin-tftv, 1 mg | 1 MG | $196.121 | 200 | — | — |
| J9274 | Injection, tebentafusp-tebn, 1 microgram | 1 MCG | $228.006 | 100 | — | — |
| J9275 | Injection, cosibelimab-ipdl, 2 mg | 2 MG | $21.989 | 600 | — | — |
| J9276 | Injection, zanidatamab-hrii, 2 mg | 2 MG | $25.734 | 1500 | — | — |
| J9277 | Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph | 1 MG | $32.307 | — | — | — |
| J9278 | Injection, carboplatin (avyxa), 1 mg | 1 MG | $5.226 | — | — | — |
| J9280 | Injection, mitomycin, 5 mg | 5 MG | $34.838 | 12 | — | — |
| J9281 | Mitomycin pyelocalyceal instillation, 1 mg | 1 MG | $329.071 | 80 | — | — |
| J9282 | Mitomycin, intravesical instillation, 1 mg | 1 MG | $272.918 | 80 | — | — |
| J9286 | Injection, glofitamab-gxbm, 2.5 mg | 2.5 MG | $2,859.117 | 12 | — | — |
| J9289 | Injection, nivolumab, 2 mg and hyaluronidase-nvhy | 2 MG | $27.989 | 600 | — | — |
| J9292 | Injection, pemetrexed dipotassium, 10 mg | 10 MG | $76.69 | 150 | — | — |
| J9293 | Injection, mitoxantrone hydrochloride, per 5 mg | 5 MG | $19.418 | 8 | — | — |
| J9294 | Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg | 10 MG | $3.678 | 150 | — | — |
| J9297 | Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg | 10 MG | $4.879 | 150 | — | — |
| J9298 | Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg | 3 mg/1 mg | $205.442 | 160 | — | — |
| J9299 | Injection, nivolumab, 1 mg | 1 MG | $34.191 | 480 | — | — |
| J9301 | Injection, obinutuzumab, 10 mg | 10 MG | $85.039 | 100 | — | — |
| J9303 | Injection, panitumumab, 10 mg | 10 MG | $183.275 | 90 | — | — |
| J9304 | Injection, pemetrexed (pemfexy), 10 mg | 10 MG | $92.505 | 150 | — | — |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 10 MG | $1.23 | 150 | — | — |
| J9306 | Injection, pertuzumab, 1 mg | 1 MG | $17.269 | 840 | — | — |
| J9307 | Injection, pralatrexate, 1 mg | 1 MG | $384.572 | 80 | — | — |
| J9308 | Injection, ramucirumab, 5 mg | 5 MG | $76.398 | 280 | — | — |
| J9309 | Injection, polatuzumab vedotin-piiq, 1 mg | 1 MG | $144.103 | 280 | — | — |
| J9311 | Injection, rituximab 10 mg and hyaluronidase | 10 mg | $36.265 | 160 | — | yes |
| J9312 | Injection, rituximab, 10 mg | 10 MG | $72.094 | 150 | — | yes |
| J9314 | Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg | 10 MG | $10.986 | 150 | — | — |
| J9316 | Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg | 10 MG | $59.491 | 180 | — | — |
| J9317 | Injection, sacituzumab govitecan-hziy, 2.5 mg | 2.5 MG | $37.536 | 648 | — | — |
| J9318 | Injection, romidepsin, non-lyophilized, 0.1 mg | 0.1 MG | $32.864 | 475 | — | — |
| J9319 | Injection, romidepsin, lyophilized, 0.1 mg | 0.1 MG | $32.343 | 500 | — | — |
| J9321 | Injection, epcoritamab-bysp, 0.16 mg | 0.16 MG | $57.975 | 300 | — | — |
| J9324 | Injection, pemetrexed (pemrydi rtu), 10 mg | 10 MG | $63.58 | 150 | — | — |
| J9325 | Injection, talimogene laherparepvec, per 1 million plaque forming units | 1 millionPFU | $77.657 | 400 | — | — |
| J9326 | Injection, telisotuzumab vedotin-tllv, 1 mg | 1 MG | $145.946 | 200 | — | — |
| J9328 | Injection, temozolomide, 1 mg | 1 MG | $10.41 | 400 | — | — |
| J9329 | Injection, tislelizumab-jsgr, 1mg | 1 MG | $58.086 | 400 | — | — |
| J9330 | Injection, temsirolimus, 1 mg | 1 MG | $27.707 | 50 | — | — |
| J9331 | Injection, sirolimus protein-bound particles, 1 mg | 1 MG | $91.03 | 300 | — | — |
| J9332 | Injection, efgartigimod alfa-fcab, 2mg | 2 MG | $32.347 | 600 | — | — |
| J9333 | Injection, rozanolixizumab-noli, 1 mg | 1 MG | $23.626 | 840 | — | — |
| J9334 | Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc | 2 MG | $33.59 | 504 | — | — |
| J9341 | Injection, thiotepa (tepylute), 1 mg | 1 MG | $37.841 | 60 | — | — |
| J9342 | Injection, thiotepa, not otherwise specified, 1 mg | 1 MG | $5.871 | 60 | — | — |
| J9345 | Injection, retifanlimab-dlwr, 1 mg | 1 MG | $30.932 | 500 | — | — |
| J9347 | Injection, tremelimumab-actl, 1 mg | 1 MG | $146.991 | 300 | — | — |
| J9348 | Injection, naxitamab-gqgk, 1 mg | 1 MG | $685.988 | 160 | — | — |
| J9349 | Injection, tafasitamab-cxix, 2 mg | 2 MG | $14.428 | 900 | — | — |
| J9350 | Injection, mosunetuzumab-axgb, 1 mg | 1 MG | $676.484 | 60 | — | — |
| J9351 | Injection, topotecan, 0.1 mg | 0.1 MG | $2.067 | 120 | — | — |
| J9353 | Injection, margetuximab-cmkb, 5 mg | 5 MG | $56.046 | 450 | — | — |
| J9354 | Injection, ado-trastuzumab emtansine, 1 mg | 1 MG | $43.86 | 600 | — | — |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 10 MG | $68.871 | 120 | — | — |
| J9356 | Injection, trastuzumab, 10 mg and hyaluronidase-oysk | 10 MG | $58.038 | 60 | — | — |
| J9357 | Injection, valrubicin, intravesical, 200 mg | 200 MG | $1,230.664 | 4 | — | — |
| J9358 | Injection, fam-trastuzumab deruxtecan-nxki, 1 mg | 1 MG | $32.653 | 1000 | — | — |
| J9359 | Injection, loncastuximab tesirine-lpyl, 0.075 mg | 0.075 MG | $226.565 | 400 | — | — |
| J9360 | Injection, vinblastine sulfate, 1 mg | 1 MG | $5.754 | 40 | — | — |
| J9361 | Injection, efbemalenograstim alfa-vuxw, 0.5 mg | 0.5 MG | $121.429 | 40 | — | — |
| J9362 | Injection, trabectedin, 0.01 mg | 0.01 MG | $41.844 | — | — | — |
| J9370 | Vincristine sulfate, 1 mg | 1 MG | $9.426 | 4 | — | — |
| J9380 | Injection, teclistamab-cqyv, 0.5 mg | 0.5 MG | $35.818 | 918 | — | — |
| J9381 | Injection, teplizumab-mzwv, 5 mcg | 5 MCG | $39.274 | 800 | — | — |
| J9382 | Injection, zenocutuzumab-zbco, 1 mg | 1 MG | $33.869 | 750 | — | — |
| J9390 | Injection, vinorelbine tartrate, 10 mg | 10 MG | $4.148 | 36 | — | — |
| J9395 | Injection, fulvestrant, 25 mg | 25 MG | $5.021 | 20 | — | — |
| J9400 | Injection, ziv-aflibercept, 1 mg | 1 MG | $9.702 | 500 | — | — |
| J9601 | Injection, linvoseltamab-gcpt, 1 mg | 1 MG | $99.134 | — | — | — |
How to read this table
The limit is the Medicare Part B payment allowance per billing unit for the quarter shown, not per dose: multiply it by the units that the administered quantity divided by the descriptor unit produces. The MUE column is the practitioner-setting Medically Unlikely Edit, the maximum units CMS expects on one date of service; facility and DME limits can differ and appear on each code page. Column-2 pairs counts the active NCCI procedure-to-procedure edits in which the code is the bundled component, and Articles marks codes that at least one Medicare Administrative Contractor lists in a current Billing and Coding Article with covered diagnosis codes. Codes without a published limit are contractor-priced or carry a zero limit in the CMS file.
Frequently asked questions
How many codes are in drugs administered other than oral method, chemotherapy drugs (j codes)?
787 codes in this range carry an ASP payment limit in the October 2026 file; 707 have enough joined CMS data (MUE, NCCI, OPPS or coverage) to be published as full reference pages.
Which payers use these payment limits?
Medicare Part B contractors apply the ASP limits directly. Medicaid programs and commercial payers publish their own fee schedules, which often reference ASP but at different percentages.
Why do some codes show no MUE?
CMS withholds some MUE values as confidential and applies them without publication; others have no unit limit. A code with no published MUE can still deny for units when the quantity is implausible for the dose.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
Disclaimer
Operational reference compiled from CMS publications. Payment limits are Medicare national amounts; other payers differ. CPT codes appear as numbers only. Not legal, clinical or billing advice.